Table 1. Baseline Characteristics of Participants Treated for Alcohol or Opioid Use Disorder by Medication Prescribed (2005).
Acamprosate Cohort (N=10,309) |
Naltrexone Cohort (N=4,389) |
Buprenorphine Cohort (N=3,320) |
Methadone Cohort (N=5,449) |
||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Characteristic | N | % | N | % | N | % | N | % | |||
Sex | |||||||||||
Women | 3,304 | 32.1 | 1,585 | 36.1 | 885 | 26.7 | 2,123 | 39.0 | |||
Men | 7,005 | 67.9 | 2,804 | 63.9 | 2,435 | 73.3 | 3,326 | 61.0 | |||
Age (years) | |||||||||||
<20 | 295 | 2.9 | 230 | 5.2 | 216 | 6.5 | 113 | 2.1 | |||
20–29 | 748 | 7.3 | 456 | 10.4 | 1,253 | 37.7 | 802 | 14.7 | |||
30–39 | 1,651 | 16.0 | 792 | 18.1 | 983 | 29.6 | 1,110 | 20.4 | |||
40–49 | 2,817 | 27.3 | 1,161 | 26.5 | 675 | 20.3 | 1,441 | 26.5 | |||
50–59 | 2,859 | 27.7 | 1,019 | 23.2 | 169 | 5.1 | 946 | 17.4 | |||
60–69 | 1,613 | 15.6 | 595 | 13.6 | 21 | 0.6 | 946 | 10.7 | |||
>69 | 326 | 3.2 | 136 | 3.1 | 3 | 0.1 | 453 | 8.3 | |||
Sociodemographic variables | |||||||||||
Unmarried or divorced | 6,469 | 62.8 | 3,015 | 68.7 | 2,862 | 89.5 | 3,575 | 69.9 | |||
Employed | 5,313 | 51.5 | 1,782 | 40.6 | 639 | 19.8 | 1,202 | 22.5 | |||
Receiving social welfare | 1,441 | 14.0 | 825 | 18.8 | 1,961 | 60.9 | 1,825 | 34.1 | |||
Receiving disability pension | 2,674 | 25.9 | 1,406 | 32.0 | 650 | 20.2 | 2,076 | 38.8 | |||
Lifetime psychiatric and substance use | |||||||||||
disorder diagnoses | |||||||||||
Alcohol use disorder | 7,685 | 74.6 | 3,426 | 78.5 | 1,146 | 34.5 | 1,251 | 23.0 | |||
Substance use disordera | 2,359 | 22.9 | 1,478 | 33.7 | 3,293 | 99.2 | 3,343 | 61.4 | |||
Psychotic disorders | 966 | 9.4 | 745 | 17.0 | 330 | 9.9 | 334 | 6.1 | |||
Bipolar disorder | 896 | 8.7 | 583 | 13.3 | 160 | 4.8 | 188 | 3.5 |
In this category, we report substance use disorders other than alcohol use disorder.